Authors

• S. Cheenu Kappadath (ORCID: https://orcid.org/0000-0003-4643-7745)
• Vanessa L. Gates (ORCID: https://orcid.org/0000-0003-4131-8640)
• Matthew R. Dreher
• Kirk D. Fowers
• Marnix G. E. H. Lam (ORCID: https://orcid.org/0000-0002-4902-9790)
• Murat Cantaşdemir (ORCID: https://orcid.org/0000-0002-1795-9635)
• Ken Herrmann
• Marco Maccauro (ORCID: https://orcid.org/0000-0003-1389-3250)
• Daniel Y. Sze (ORCID: https://orcid.org/0000-0002-6885-0752)
• Brian Geller (ORCID: https://orcid.org/0000-0002-8452-2601)
• Cüneyt Türkmen (ORCID: https://orcid.org/0000-0003-0912-8214)
• Alban Denys (ORCID: https://orcid.org/0000-0002-2275-7384)
• Paul Haste
• Riad Salem (ORCID: https://orcid.org/0000-0001-9745-1825)
• Étienne Garin (ORCID: https://orcid.org/0000-0003-1416-2863)
• Hamad Saleh Alsuhaibani

Institutions

• Northwestern University (US)
• The University of Texas MD Anderson Cancer Center (US)
• Istanbul Aydın University (TR)
• Utrecht University (NL)
• Heidelberg University (DE)
• King Faisal Specialist Hospital & Research Centre (SA)
• University Hospital Heidelberg (DE)
• Centre Hospitalier Universitaire Vaudois (CH)
• Boston Scientific (United States) (US)
• University Medical Center Utrecht (NL)
• University of Florida (US)
• Istanbul Florence Nightingale Hospital (TR)
• Centre Eugène Marquis (FR)
• Essen University Hospital (DE)
• Stanford Medicine (US)
• Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
• West German Heart and Vascular Center Essen (DE)
• Indiana University School of Medicine
• Indiana University – Purdue University Indianapolis (US)
• University of Duisburg-Essen (DE)
• Istanbul University (TR)
• Stanford University (US)
• University of Lausanne (CH)

Publication Details

Journal

European Journal of Nuclear Medicine and Molecular Imaging

Published

2024-09-27

DOI

https://doi.org/10.1007/s00259-024-06920-6

Citations

2

Primary Topic

Hepatocellular Carcinoma Treatment and Prognosis

Type

article

Field-Weighted Citation Impact

0.74

Funders

• Boston Scientific Corporation